WealthShield Partners’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

WealthShield Partners’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,000	Closed	-$28K	–	796
2021 Q2	$28K	Hold	1,000	–	–	﹤0.01%	598
2021 Q1	$16K	Buy	+1,000	New	+$22.8K	﹤0.01%	715

WealthShield Partners's TBIO Position: Q3 2021 in Review

WealthShield Partners sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 1,000 shares — an estimated $28K sold.

WealthShield Partners first reported a position in TBIO in Q1 2021 and held it in 2 quarters. The position peaked at $28K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

WealthShield Partners reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
WealthShield Partners sold 1,000 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $28K.
WealthShield Partners first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
WealthShield Partners's Translate Bio, Inc. Common Stock position peaked at $28K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on WealthShield Partners's 13F filing for Q3 2021, filed 12 Nov 2021.